SEC Form 4 · accession 0001209191-16-096109
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent P Ippolito
Officer — EVP & Chief Commercial Officer
Period of report
Feb 3, 2016
Accepted (ET)
Feb 5, 2016 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 3, 2016 | A | 5,000 | $0.00 | A | 76,985 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $78.91 | Feb 3, 2016 | A | 25,299 | A | — | Feb 3, 2026 | Common Stock | 25,299 | 25,299 | D |
| Performance Restricted Stock UnitsF4 | — | Feb 3, 2016 | A | 5,000 | A | — | — | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2016.
- F2Includes shares purchased in 2016 pursuant to the Issuer's ESPP.
- F3The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date is January 1, 2016.
- F4Represents performance restricted stock units granted to the Reporting Person. Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and will vest, if at all, based on the achievement of certain specified performance goals.